Contract Manufacturing - Biologics
Total Trials
21
As Lead Sponsor
20
As Collaborator
1
Total Enrollment
1,458
NCT00423124
Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 31, 2002
Completion: Nov 30, 2013
NCT00419328
A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors
Phase: Phase 1
Start: Mar 31, 2005
Completion: Sep 30, 2007
NCT00305084
Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
Start: Feb 28, 2006
Completion: May 8, 2007
NCT00483080
Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC)
Phase: Phase 2
Start: Dec 31, 2006
Completion: Apr 30, 2013
NCT00484211
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)
NCT00483509
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma
Start: Feb 14, 2007
Completion: May 17, 2011
NCT00484276
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma
Start: May 31, 2007
Completion: Mar 31, 2013
NCT00483093
Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor
Start: Jul 31, 2007
NCT00675012
NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer
Start: Dec 31, 2007
Completion: May 31, 2013
NCT00484432
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer
Start: Nov 30, 2008
Completion: Jun 30, 2016
NCT00878111
Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour
Start: Apr 30, 2009
Completion: Feb 28, 2017
NCT00994097
NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer
Start: Jul 31, 2009
Completion: Mar 31, 2017
NCT00914628
Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia
Phase: Phase 3
Start: Apr 12, 2010
Completion: Nov 30, 2019
NCT01098266
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Completion: Dec 31, 2017
NCT00484341
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.
Start: Oct 31, 2010
Completion: May 31, 2016
NCT01358084
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM
Start: Mar 31, 2011
Completion: Dec 5, 2018
NCT01358071
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
Start: Jun 30, 2011
Completion: Dec 31, 2016
NCT03804866
NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
Start: Mar 31, 2013
NCT02307448
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds
Phase: N/A
Start: Aug 31, 2015
Completion: Dec 31, 2022
NCT03536039
RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor
Role: Collaborator
Start: Jan 27, 2016
Completion: Jan 27, 2020
NCT04097301
Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma
Start: Aug 27, 2019
Completion: Jun 18, 2021
Loading map...